The Multifaceted Zoonotic Risk of H9N2 Avian Influenza
- PMID: 30248906
- PMCID: PMC6313933
- DOI: 10.3390/vetsci5040082
The Multifaceted Zoonotic Risk of H9N2 Avian Influenza
Abstract
Poultry-adapted H9N2 avian influenza viruses (AIVs) are commonly found in many countries in Asia, the Middle East, Africa, and Europe, and although classified as low pathogenic viruses, they are an economically important disease. Besides the importance of the disease in the poultry industry, some H9N2 AIVs are also known to be zoonotic. The disease in humans appears to cause primarily a mild upper respiratory disease, and doesn't cause or only rarely causes the severe pneumonia often seen with other zoonotic AIVs like H5N1 or H7N9. Serologic studies in humans, particularly in occupationally exposed workers, show a large number of people with antibodies to H9N2, suggesting infection is commonly occurring. Of the four defined H9N2 poultry lineages, only two lineages, the G1 and the Y280 lineages, are associated with human infections. Almost all of the viruses from humans have a leucine at position 226 (H3 numbering) of the hemagglutinin associated with a higher affinity of binding with α2,6 sialic acid, the host cell receptor most commonly found on glycoproteins in the human upper respiratory tract. For unknown reasons there has also been a shift in recent years of poultry viruses in the G1 and Y280 lineages to also having leucine instead of glutamine, the amino acid found in most avian viruses, at position 226. The G1 and Y280 poultry lineages because of their known ability to infect humans, the high prevalence of the virus in poultry in endemic countries, the lack of antibody in most humans, and the shift of poultry viruses to more human-like receptor binding makes these viruses a human pandemic threat. Increased efforts for control of the virus, including through effective vaccine use in poultry, is warranted for both poultry and public health goals.
Keywords: H9N2; avian influenza; human infection; zoonotic.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Infectivity and Transmissibility of Avian H9N2 Influenza Viruses in Pigs.J Virol. 2016 Jan 13;90(7):3506-14. doi: 10.1128/JVI.02605-15. J Virol. 2016. PMID: 26764002 Free PMC article.
-
H9N2 Influenza Virus Infections in Human Cells Require a Balance between Neuraminidase Sialidase Activity and Hemagglutinin Receptor Affinity.J Virol. 2020 Aug 31;94(18):e01210-20. doi: 10.1128/JVI.01210-20. Print 2020 Aug 31. J Virol. 2020. PMID: 32641475 Free PMC article.
-
First report of field cases of Y280-like LPAI H9N2 strains in South Korean poultry farms: pathological findings and genetic characterization.Avian Pathol. 2021 Aug;50(4):327-338. doi: 10.1080/03079457.2021.1929833. Epub 2021 Jul 12. Avian Pathol. 2021. PMID: 34013789
-
Sporadic occurrence of H9N2 avian influenza infections in human in Anhui province, eastern China: A notable problem.Microb Pathog. 2020 Mar;140:103940. doi: 10.1016/j.micpath.2019.103940. Epub 2019 Dec 18. Microb Pathog. 2020. PMID: 31863839
-
Challenge for One Health: Co-Circulation of Zoonotic H5N1 and H9N2 Avian Influenza Viruses in Egypt.Viruses. 2018 Mar 9;10(3):121. doi: 10.3390/v10030121. Viruses. 2018. PMID: 29522492 Free PMC article. Review.
Cited by
-
Incidence and Seroprevalence of Avian Influenza in a Cohort of Backyard Poultry Growers, Egypt, August 2015-March 2019.Emerg Infect Dis. 2020 Sep;26(9):2129-2136. doi: 10.3201/eid2609.200266. Emerg Infect Dis. 2020. PMID: 32818403 Free PMC article.
-
Selection of an Optimal Recombinant Egyptian H9N2 Avian Influenza Vaccine Strain for Poultry with High Antigenicity and Safety.Vaccines (Basel). 2022 Jan 21;10(2):162. doi: 10.3390/vaccines10020162. Vaccines (Basel). 2022. PMID: 35214621 Free PMC article.
-
Prevalence and risk factor for H9N2 avian influenza virus in poultry retail shops of Madhya Pradesh.Virusdisease. 2024 Jun;35(2):321-328. doi: 10.1007/s13337-024-00865-y. Epub 2024 May 16. Virusdisease. 2024. PMID: 39071868 Free PMC article.
-
Vaccination and Antiviral Treatment against Avian Influenza H5Nx Viruses: A Harbinger of Virus Control or Evolution.Vaccines (Basel). 2023 Oct 24;11(11):1628. doi: 10.3390/vaccines11111628. Vaccines (Basel). 2023. PMID: 38005960 Free PMC article. Review.
-
Diversity and distribution of type A influenza viruses: an updated panorama analysis based on protein sequences.Virol J. 2019 Jun 26;16(1):85. doi: 10.1186/s12985-019-1188-7. Virol J. 2019. PMID: 31242907 Free PMC article.
References
-
- Guan Y., Shortridge K.F., Krauss S., Chin P.S., Dyrting K.C., Ellis T.M., Webster R.G., Peiris M. H9N2 influenza Viruses possessing H5N1-like internal genomes continue to circulate in poultry in southeastern China. J. Virol. 2000;74:9372–9380. doi: 10.1128/JVI.74.20.9372-9380.2000. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources